DePuy Orthopaedics, Inc. Gets FDA Clearance for TruMatch Device

DePuy Orthopaedics Inc. landed clearance for its TruMatch surgical customization system for use with its Sigma fixed-bearing knee replacement device. That means the Warsaw, Ind.-based Johnson & Johnson (NYSE:JNJ) subsidiary no longer has to worry about the FDA's past warnings over illegal marketing of the device on its website. "TruMatch technology helps surgeons consistently provide knee replacement patients a customized fit and enables them to do the operation in less time," Dr. Daniel Hoeffel of Summit Orthopaedic Group said in prepared remarks.